Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Parabilis Medicines, Inc.
Myeloid Therapeutics
Incyte Corporation
Incyte Corporation
University of Chicago